Postnatal Foxp2 regulates early psychiatric-like phenotypes and associated molecular alterations in the R6/1 transgenic mouse model of Huntington's disease

dc.contributor.author
Rodríguez Urgellés, Ened
dc.contributor.author
Rodríguez Navarro, Irene
dc.contributor.author
Ballasch, Iván
dc.contributor.author
Toro Ruiz, Daniel del
dc.contributor.author
Del Castillo, Ignacio
dc.contributor.author
Brito, Verónica
dc.contributor.author
Alberch i Vié, Jordi, 1959-
dc.contributor.author
Giralt Torroella, Albert
dc.date.issued
2023-06-27T13:38:40Z
dc.date.issued
2023-06-27T13:38:40Z
dc.date.issued
2022-09-24
dc.date.issued
2023-06-27T13:38:40Z
dc.identifier
0969-9961
dc.identifier
https://hdl.handle.net/2445/199962
dc.identifier
730219
dc.identifier
9329135
dc.identifier
36029989
dc.description.abstract
Huntington's Disease (HD) is a devastating disorder characterized by a triad of motor, psychiatric and cognitive manifestations. Psychiatric and emotional symptoms appear at early stages of the disease which are consistently described by patients and caregivers among the most disabling. Here, we show for the first time that Foxp2 is strongly associated with some psychiatric-like disturbances in the R6/1 mouse model of HD. First, 4-week-old (juvenile) R6/1 mice behavioral phenotype was characterized by an increased impulsive-like behavior and less aggressive-like behavior. In this line, we identified an early striatal downregulation of Foxp2 protein starting as soon as at postnatal day 15 that could explain such deficiencies. Interestingly, the rescue of striatal Foxp2 levels from postnatal stages completely reverted the impulsivity-phenotype and partially the social impairments concomitant with a rescue of dendritic spine pathology. A mass spectrometry study indicated that the rescue of spine loss was associated with an improvement of several altered proteins related with cytoskeleton dynamics. Finally, we reproduced and mimicked the impulsivity and social deficits in wild type mice by reducing their striatal Foxp2 expression from postnatal stages. Overall, these results imply that early postnatal reduction of Foxp2 might contribute to the appearance of some of the early psychiatric symptoms in HD.
dc.format
12 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
Elsevier
dc.relation
Reproducció del document publicat a: https://doi.org/10.1016/j.nbd.2022.105854
dc.relation
Neurobiology of Disease, 2022, vol. 173, p. 105854
dc.relation
https://doi.org/10.1016/j.nbd.2022.105854
dc.rights
cc-by-nc-nd (c) Elsevier, 2022
dc.rights
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Biomedicina)
dc.subject
Ratolins transgènics
dc.subject
Hiperactivitat
dc.subject
Impulsos (Psicologia)
dc.subject
Proteòmica
dc.subject
Habilitats socials
dc.subject
Múscul estriat
dc.subject
Corea de Huntington
dc.subject
Transgenic mice
dc.subject
Hyperactivity
dc.subject
Impulse
dc.subject
Proteomics
dc.subject
Social skills
dc.subject
Striated muscle
dc.subject
Huntington's chorea
dc.title
Postnatal Foxp2 regulates early psychiatric-like phenotypes and associated molecular alterations in the R6/1 transgenic mouse model of Huntington's disease
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Fitxers en aquest element

FitxersGrandàriaFormatVisualització

No hi ha fitxers associats a aquest element.